LTRN - Lantern Pharma Inc
2.7
-0.060 -2.222%
Share volume: 31,301
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$2.76
-0.06
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-07-2024 | 03-27-2025 | 05-15-2025 | 11-12-2025 | |
| Cash flow financing | 54.716 K | 0.000 | 11.994 K | 0.000 | 0.000 | 971.781 K | |
| Other financing cash flows | 54.716 K | 0.000 | 11.994 K | 0.000 | 0.000 | 13.442 K | |
| Cash flow | -3.570 M | 0.000 | -4.890 M | 0.000 | -1.136 M | 2.328 M | |
| Net income | -5.441 M | -4.960 M | -4.506 M | -5.875 M | -4.537 M | -4.177 M | |
| Depreciation | 4.061 K | 4.258 K | 4.389 K | 4.574 K | 4.574 K | 4.102 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -556.168 K | -202.063 K | 680.345 K | 3.447 M | 3.239 M | 5.929 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 2.217 K | 4.267 K | 3.028 K | 3.083 K | 1.159 K | 555.000 | |
| Cash Change | -3.580 M | -5.381 M | -4.874 M | -591.740 K | -1.133 M | 2.328 M |